• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.紫杉烷类诱导的感觉周围神经病与日本患者 SCN9A 单核苷酸多态性相关。
BMC Cancer. 2020 Apr 16;20(1):325. doi: 10.1186/s12885-020-06834-0.
2
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.ECOG-ACRIN EAZ171:在早期乳腺癌的黑人女性中,前瞻性验证研究种系预测紫杉醇诱导的周围神经病变的试验。
J Clin Oncol. 2024 Aug 20;42(24):2899-2907. doi: 10.1200/JCO.24.00526. Epub 2024 Jun 3.
3
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.SCN9A基因多态性与奥沙利铂所致神经病变相关。
BMC Cancer. 2017 Jan 19;17(1):63. doi: 10.1186/s12885-016-3031-5.
4
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.ECOG-5103和ECOG-1199中紫杉烷诱导的周围神经病变的全基因组关联研究
Clin Cancer Res. 2015 Nov 15;21(22):5082-5091. doi: 10.1158/1078-0432.CCR-15-0586. Epub 2015 Jul 2.
5
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.与非裔美国人紫杉烷诱导的周围神经病变相关的夏科-马里-图思基因SBF2
Oncotarget. 2016 Dec 13;7(50):82244-82253. doi: 10.18632/oncotarget.12545.
6
Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.紫杉烷类药物所致周围神经病变:乳腺癌患者中紫杉醇与多西他赛的客观与主观比较
Clin J Oncol Nurs. 2019 Oct 1;23(5):494-501. doi: 10.1188/19.CJON.494-501.
7
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.血清钠离子和氯离子与中国早期乳腺癌患者紫杉烷类诱导的周围神经病变相关:一项全国多中心研究。
Breast. 2023 Feb;67:36-45. doi: 10.1016/j.breast.2022.12.034. Epub 2022 Dec 28.
8
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.全基因组荟萃分析确定了新的紫杉烷诱导的周围神经病变相关基因座。
Pharmacogenet Genomics. 2018 Feb;28(2):49-55. doi: 10.1097/FPC.0000000000000318.
9
Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.接受治疗的乳腺癌患者中紫杉烷类药物所致周围神经病变的发生率及处方模式
Support Care Cancer. 2017 Jul;25(7):2241-2248. doi: 10.1007/s00520-017-3631-x. Epub 2017 Feb 16.
10
Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.纳布紫杉醇在年轻与老年转移性HR阳性/HER2阴性乳腺癌患者中的有效性和耐受性:非干预性前瞻性研究NABUCCO的结果
Clin Breast Cancer. 2020 Jun;20(3):e315-e326. doi: 10.1016/j.clbc.2019.11.003. Epub 2020 Mar 10.

引用本文的文献

1
Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencing.利用全外显子组测序预测乳腺癌幸存者中紫杉烷诱导的持续性周围神经病变的模型
NPJ Precis Oncol. 2024 May 16;8(1):102. doi: 10.1038/s41698-024-00594-x.
2
Phylogenetic Analysis Provides Insight Into the Molecular Evolution of Nociception and Pain-Related Proteins.系统发育分析为伤害感受和疼痛相关蛋白的分子进化提供了见解。
Evol Bioinform Online. 2023 Dec 14;19:11769343231216914. doi: 10.1177/11769343231216914. eCollection 2023.
3
A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.一种用于发现紫杉醇诱导的周围神经病(TIPN)生物标志物的多模态方法:研究方案。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221127169. doi: 10.1177/15330338221127169.
4
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity.个体化医学时代的副作用管理:化疗诱导的周围神经毒性。
Methods Mol Biol. 2022;2547:95-140. doi: 10.1007/978-1-0716-2573-6_5.
5
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.紫杉醇类药物所致乳腺癌神经毒性的遗传药理学:系统评价和荟萃分析。
Clin Transl Sci. 2022 Oct;15(10):2403-2436. doi: 10.1111/cts.13370. Epub 2022 Aug 17.
6
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions.化疗诱导的周围神经病变的生物标志物:现状与未来方向
Front Pain Res (Lausanne). 2022 Mar 14;3:864910. doi: 10.3389/fpain.2022.864910. eCollection 2022.
7
Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain.通过抑制CRMP2-Ubc9相互作用靶向NaV1.7的小分子可减轻并预防奥沙利铂诱导的神经性疼痛小鼠模型中的疼痛慢性化。
Neurobiol Pain. 2021 Dec 27;11:100082. doi: 10.1016/j.ynpai.2021.100082. eCollection 2022 Jan-Jul.
8
Goshajinkigan attenuates paclitaxel-induced neuropathic pain via cortical astrocytes.升麻苷元通过皮质星形胶质细胞减轻紫杉醇诱导的神经病理性疼痛。
Pharmacol Res Perspect. 2021 Dec;9(6):e00850. doi: 10.1002/prp2.850.

本文引用的文献

1
Na channel variants in patients with painful and nonpainful peripheral neuropathy.疼痛性和非疼痛性周围神经病变患者的钠通道变体
Neurol Genet. 2017 Dec 15;3(6):e207. doi: 10.1212/NXG.0000000000000207. eCollection 2017 Dec.
2
DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.DRG 电压门控钠离子通道 1.7 在紫杉醇诱导的大鼠神经病变和人类神经性疼痛中上调。
J Neurosci. 2018 Jan 31;38(5):1124-1136. doi: 10.1523/JNEUROSCI.0899-17.2017. Epub 2017 Dec 18.
3
Association of Voltage-Gated Sodium Channel Genetic Polymorphisms with Oxaliplatin-Induced Chronic Peripheral Neuropathy in South Indian Cancer Patients.电压门控钠通道基因多态性与南印度癌症患者奥沙利铂诱导的慢性周围神经病变的关联
Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3157-3165. doi: 10.22034/APJCP.2017.18.11.3157.
4
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.在日本,紫杉醇引起的感觉性周围神经病变与ABCB1单核苷酸多态性及年龄较大有关。
Cancer Chemother Pharmacol. 2017 Jun;79(6):1179-1186. doi: 10.1007/s00280-017-3314-9. Epub 2017 Apr 26.
5
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.SCN9A基因多态性与奥沙利铂所致神经病变相关。
BMC Cancer. 2017 Jan 19;17(1):63. doi: 10.1186/s12885-016-3031-5.
6
Na1.7 as a pain target - From gene to pharmacology.作为疼痛靶点的Na1.7——从基因到药理学
Pharmacol Ther. 2017 Apr;172:73-100. doi: 10.1016/j.pharmthera.2016.11.015. Epub 2016 Dec 2.
7
Sodium channel Nav1.7 expression is upregulated in the dorsal root ganglia in a rat model of paclitaxel-induced peripheral neuropathy.在紫杉醇诱导的周围神经病变大鼠模型中,背根神经节中钠通道Nav1.7的表达上调。
Springerplus. 2016 Oct 6;5(1):1738. doi: 10.1186/s40064-016-3351-6. eCollection 2016.
8
Genotypic Analysis of SCN9A for Prediction of Postoperative Pain in Female Patients Undergoing Gynecological Laparoscopic Surgery.SCN9A基因分型分析对妇科腹腔镜手术女性患者术后疼痛的预测作用
Pain Physician. 2016 Jan;19(1):E151-62.
9
Primary erythromelalgia: a review.原发性红斑性肢痛症:综述
Orphanet J Rare Dis. 2015 Sep 30;10:127. doi: 10.1186/s13023-015-0347-1.
10
The Effect of SCN9A Variation on Basal Pain Sensitivity in the General Population: An Experimental Study in Young Women.SCN9A基因变异对普通人群基础疼痛敏感性的影响:一项针对年轻女性的实验研究。
J Pain. 2015 Oct;16(10):971-80. doi: 10.1016/j.jpain.2015.06.011. Epub 2015 Jul 11.

紫杉烷类诱导的感觉周围神经病与日本患者 SCN9A 单核苷酸多态性相关。

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.

机构信息

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.

出版信息

BMC Cancer. 2020 Apr 16;20(1):325. doi: 10.1186/s12885-020-06834-0.

DOI:10.1186/s12885-020-06834-0
PMID:32295642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7161266/
Abstract

BACKGROUND

Sodium channels located in the dorsal root ganglion, particularly Nav1.7 and Nav1.8, encoded by SCN9A and SCN10A, respectively, act as molecular gatekeepers for pain detection. Our aim was to determine the association between TIPN and SCN9A and SCN10A polymorphisms.

METHODS

Three single nucleotide polymorphisms (SNPs) in SCN9A and two in SCN10A were investigated using whole-genome genotyping data from 186 Japanese breast or ovarian cancer patients classified into two groups as follows: cases that developed taxane-induced grade 2-3 neuropathy (N = 108) and controls (N = 78) with grade 0-1 neuropathy. Multiple logistic regression analyses were conducted to evaluate associations between TIPN and SNP genotypes.

RESULTS

SCN9A-rs13017637 was a significant predictor of grade 2 or higher TIPN (odds ratio (OR) = 3.463; P = 0.0050) after correction for multiple comparisons, and precision was improved when only breast cancer patients were included (OR 5.053, P = 0.0029). Moreover, rs13017637 was a significant predictor of grade 2 or higher TIPN 1 year after treatment (OR 3.906, P = 0.037), indicating its contribution to TIPN duration.

CONCLUSION

SCN9A rs13017637 was associated with the severity and duration of TIPN. These findings are highly exploratory and require replication and validation prior to any consideration of clinical use.

摘要

背景

位于背根神经节的钠通道,特别是分别由 SCN9A 和 SCN10A 编码的 Nav1.7 和 Nav1.8,充当疼痛检测的分子门控。我们的目的是确定 TIPN 与 SCN9A 和 SCN10A 多态性之间的关联。

方法

使用来自 186 名日本乳腺癌或卵巢癌患者的全基因组基因分型数据,对 SCN9A 中的三个单核苷酸多态性(SNP)和 SCN10A 中的两个 SNP 进行了研究,这些患者分为两组:发生紫杉醇诱导的 2-3 级神经病变的病例(N=108)和 0-1 级神经病变的对照组(N=78)。进行了多变量逻辑回归分析,以评估 TIPN 与 SNP 基因型之间的关联。

结果

SCN9A-rs13017637 是 2 级或更高 TIPN 的显著预测因子(比值比(OR)=3.463;P=0.0050),在经过多次比较校正后,并且当仅包括乳腺癌患者时,精度得到提高(OR 5.053,P=0.0029)。此外,rs13017637 是治疗后 1 年 2 级或更高 TIPN 的显著预测因子(OR 3.906,P=0.037),表明其对 TIPN 持续时间的贡献。

结论

SCN9A rs13017637 与 TIPN 的严重程度和持续时间相关。这些发现具有高度探索性,在考虑临床应用之前,需要进行复制和验证。